# Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

> **NCT00230399** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 15 (—)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Capecitabine
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00230399
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-01
- **Final completion:** 2008-03
- **Target enrollment:** 15 (—)
- **Last updated:** 2015-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230399, "Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00230399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*